CLOV vs MOH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CLOV

34.3
AI Score
VS
MOH Wins

MOH

37.8
AI Score

Investment Advisor Scores

CLOV

34score
Recommendation
SELL

MOH

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric CLOV MOH Winner
Forward P/E 81.9672 38.1679 MOH
PEG Ratio 0 1.7888 Tie
Revenue Growth 55.6% -5.7% CLOV
Earnings Growth 0.0% -75.3% CLOV
Tradestie Score 34.3/100 37.8/100 MOH
Profit Margin -0.7% -0.0% MOH
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

CLOV 1M: -8.8% · 3M: +15.3% MOH 1M: +0.0% · 3M: +10.5%

Current Technical Phase

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $4.15

MOH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.5 · Price: $200.29

Fundamentals Snapshot

Metric CLOV MOH
Market Cap
Forward P/E 27.7 23.4
Trailing P/E 1230.9
Revenue (TTM)
Revenue Growth 0.6% -0.1%
Gross Margin 0.2% 0.1%
Operating Margin 0.0% 0.0%
EPS -0.05 0.16
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MOH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.